Expert Talks the Who, What and When of Breast Cancer Genetic Testing – Curetoday.com
Posted By admin on November 25, 2021
Its a question asked at many doctor visits: What is your family health history? When applied to breast cancer risk and prevention, knowing the answer can save lives.
At the recent CURE Educated Patient Breast Cancer Summit, Dr. Leif Ellisen delved into the topics of inherited breast cancer risk, genetic testing and management, so that patients can be armed with the correct information prior to their doctor visit.
It's important for all of us to remember that most breast cancer in society is not caused by genetic causes, it's caused by individual risk factors. And frankly, bad luck, said Ellisen, who is the program director of breast medical oncology and clinical director of breast and ovarian cancer genetics at Massachusetts General Hospital. That's not to say we can't do things to decrease our risk, but that ultimately, most breast cancers are not caused by hereditary factors.
Currently, breast cancers that are caused by individual genes that increase risk of breast and other cancers can be focused on in terms of clinical management.
In the future, we'll have probably better markers for breast cancers that are caused by the sum of many different genes we inherit, Ellisen said.
The genes that put someone at high risk for breast cancer are very uncommon in the general population. Low- or moderate-risk genes are more common, but the risk of breast cancer from them is lower and thus they give rise to fewer breast cancers.
Who Needs Genetic Testing?
While breast cancer caused by hereditary factors is not super common, patients may still wonder if theyre one of the unlucky few. Ellisen highlighted several red flags for hereditary breast and ovarian cancer that signify whether someone should undergo genetic testing.
Anyone with ovarian cancer (at any age) should be tested if theres a family history (on either side) and the person who had ovarian cancer cant be tested, other family members should be. Those diagnosed with triple-negative breast cancer of any stage should undergo testing, as well as anyone who received a breast cancer diagnosis before age 50. Male breast cancer is uncommon, and any family history of it signifies there could be hereditary breast cancer in the family; therefore, relatives should be tested. People who have had multiple primary cancers should be tested, as that is also a possible sign of inherited risk.
Individuals with Ashkenazi Jewish ancestry should also be tested, as BRCA1 and BRCA2 mutations occur in about one in 40 of Ashkenazi Jewish people.
Lastly, if an individual is known to have a mutation, their close family members should be tested as well.
What Genetic Tests Look For
Genetic tests vary, as there are many different types in terms of what genes theyre testing for and which company is providing the test.
It turns out that most folks now are recommended to have multi-gene panel testing somewhere between seven to nine and 30 or more genes testing for hereditary cancer, Ellisen explained.
What an individual is tested for may depend on their family history and potential risk. For example, for someone with a family history of ovarian cancer, there is a whole series of genes to test for.
For folks who have a mixed family cancer history maybe a mix of breast cancer, ovarian cancer, kidney cancer, colon cancer more than 30 genes might be indicated, in some cases, Ellisen said.
The important takeaway is that patients should speak with their health care provider about what kind of genes theyll be tested for.
Interpreting test report
Understanding the findings of a genetic test can get confusing, even for health care providers, Ellisen clarified.
We categorize the findings of genetic testing into things that are meaningful, and those are called deleterious or suspected deleterious. Another term that's used is pathogenic so pathogenic or likely pathogenic.
Whether or not a mutation is deleterious will impact how the patients health is managed.
There is also something called a variant of uncertain significance (VUS), which are very common but should typically not be used to inform decisions on screening, surgery or therapy.
And so you might ask the question, Well, if we don't know, meaning there's unknown significance, should I really be worried about this gene, whether it means something? Ellisen said. And these differences of these VUS (findings), most of them are literally like the difference between your fingerprint and mine. Yes, it's a difference. But no, it doesn't mean anything in terms of your health. And that's why often there's a controversy about whether we even need to report VUS, but definitely they should not be used importantly to guide management.
Risk Assessment and Screening Recommendations
If a patient is found to carry a certain mutation that puts them at risk for breast cancer, the next steps may vary depending on what type of mutation it is.
For the two most common breast and ovarian cancer genes, BRCA1 and BRCA2, its important to factor in a patients age. Breast cancer occurs earlier (with these mutations) than ovarian cancer.
Typically, theres a 10-year window when breast cancers occur, as early as the 20s and 30s, whereas most ovarian cancers occur in the late 40s and beyond with BRCA1 and 2, Ellisen said. And that affects how we screen, and that affects how we manage these.
For BRCA1 and BRCA 2 carriers, semiannual clinical breast screenings begin at age 25, while self-exams should be done monthly starting at age 18. Women with BRCA2 are recommended to have both an MRI and mammogram done each year after 30 (with MRI screenings beginning at age 25). The health care providers may also discuss the option of preventive mastectomy with patients and removing the ovaries and tubes not always the uterus.
This can prevent the cancers. And the main choice is about doing it at the right age. It needs to be considered at a younger age for BRCA, Ellisen added.
Beyond BRCA1 and BRCA2, there are several other common genes found through testing that are important to know about, because the recommendations differ. These include ATM, CHEK2, PALB2, PTEN, TP53 and NBN. Because the risk for breast cancer varies among them depending on the gene, some patients may be directed to undergo screenings while others may be encouraged to have a preventive mastectomy.
For the genes considered high-risk (TP53, PTEN, CDH1), providers may discuss screening or preventive mastectomy. For the more moderate-risk genes (PALB2, ATM, CHEK2, STK11), the recommendation is to undergo screening (at a later age than for high-risk genes) and discuss mastectomy if the family history shows red flags.
How Do Genes Factor Into Treatment?
PARP inhibitors were designed with the goal of complementing and providing effective therapy for tumors caused by BRCA1 and BRCA2, Ellisen explained. Theyve demonstrated successful results in breast, ovarian, pancreas and prostate cancers.
What's very exciting is it looks like PARP inhibitors are actually preventing the ultimate development of metastasis, he said.
For more news on cancer updates, research and education, dont forget tosubscribe to CUREs newsletters here.
Originally posted here:
Expert Talks the Who, What and When of Breast Cancer Genetic Testing - Curetoday.com
- Meet? Meh. Zoom? Zzz. Here's the future of online meetings - Fast Company - May 27th, 2022
- 8 tips to help journalists cover antisemitism and avoid spreading it - Journalist's Resource - May 27th, 2022
- When is Shavuot 2022? Date of Jewish holiday | NationalWorld - NationalWorld - May 27th, 2022
- Is is colon cancer hereditary or genetic? - Medical News Today - May 27th, 2022
- Advanced amphibious landing capabilities improve Israel's ability to win - JNS.org - May 27th, 2022
- Boom, there was a community: Washingtons Jewish future guided by history - MyNorthwest - May 27th, 2022
- Only countries that continue to innovate can lead - CTech - May 27th, 2022
- Rescuing Ladino from the Flames of History - aish.com - Aish - May 2nd, 2022
- By the numbers, corporate progress on gender diversity is a failure - CNBC - May 2nd, 2022
- On National Rugelach Day, A Look Into the History of Rugelach in NYC - Untapped New York - May 2nd, 2022
- As Montreal as? The mystery of the cheese bagel - Montreal Gazette - May 2nd, 2022
- World steps up fight against polio as new cases surface in Pakistan and Israel - The National - May 2nd, 2022
- How Richmond Restaurant JewFro Is Working to Bring Together Two Local Histories - Bon Appetit - May 2nd, 2022
- 'I live in peace with my two identities, Jewish and Arab - Haaretz - May 2nd, 2022
- Exhibit of Photographs and Family Artifacts Tells Little Known Story of Jewish Community in Shanghai - Broadway World - April 25th, 2022
- Local Authors, Local Books: Irvington Writer Unlocks the Mystery of Her Family - River Journal Staff - April 25th, 2022
- Students Partner with Holocaust Museum in Documenting Oral Histories of Latinx Sephardic Jewish Communities - University of Houston - April 25th, 2022
- Ashes On The Kotel: Analysis Of A Tense Situation - VINnews - April 25th, 2022
- Activist gets candid about pollution fears: 'Climate anxiety is real, especially for a young Indigenous woman' - Yahoo Singapore News - April 25th, 2022
- Get rid of that extra matzah with this Spinach Feta Matzah Brei J. - The Jewish News of Northern California - April 25th, 2022
- Fallopian Tube Cancer: Causes, Symptoms, Prevention and treatment - Rising Kashmir - April 25th, 2022
- Why this classic Romanian-Jewish dish is nearly impossible to find - Salon - March 22nd, 2022
- PART III: Confronting the elephant in the room the explosive issue of IQ - Genetic Literacy Project - March 22nd, 2022
- How the Academy Museums Jewish Exclusion Became Exhibit A - Hollywood Reporter - March 22nd, 2022
- Are virtual minyans and avatar rabbis the future of Judaism? - Forward - March 22nd, 2022
- Pancreatic Cancer Signs Scaring Doctors Most Eat This Not That - Eat This, Not That - March 22nd, 2022
- A Brief History of the Jewdle - Tablet Magazine - March 18th, 2022
- CORRECTING and REPLACING: Verimatrix Selected to Safeguard Alphazet's Streaming Service - Business Wire - March 18th, 2022
- Mila Kunis Net Worth, Salary, Investments and More - TheTealMango - March 18th, 2022
- A rabbi, a clown and a sushi chef walk into a restaurant. They're here to celebrate Purim - The Arizona Republic - March 18th, 2022
- Bill Ackmans Net Worth, Financial Situation, and Investments - The Shahab - March 10th, 2022
- Resituating US History in a Global Context | Higher Ed Gamma - Inside Higher Ed - March 10th, 2022
- Opinion: When the next Cascadia megaquake strikes, here's what I'll do - temblor - March 8th, 2022
- Watch now: Ukraine is on the minds of these musicians - Madison.com - March 8th, 2022
- Six Wintry SFF Romances That Will Melt Your Heart - tor.com - March 8th, 2022
- A UWM scholar is lending his Yiddish expertise to the provocative drama 'Indecent' at Milwaukee Chamber Theatre - Milwaukee Journal Sentinel - March 8th, 2022
- Whats between a vaccine, the most common smartphone processor, and autonomous vehicles - CTech - March 8th, 2022
- Ukraine, Anatevka, and the waters edge - The Jewish Standard - February 24th, 2022
- Woman horrified to discover gynaecologist helping her to conceive was really her father - JOE.co.uk - February 24th, 2022
- Beyond 'tash, Purim tables laden with diversity - The Jewish Star - February 24th, 2022
- 'Shababnikim' offers a fresh, funny picture of Israeli Orthodox life J. - The Jewish News of Northern California - February 24th, 2022
- Gene tests show that two fifths of Ashkenazi Jews are ... - February 23rd, 2022
- Types of Jews - My Jewish Learning - February 23rd, 2022
- Gal Gadot Enjoys her Sunday with a Bowl of Goodles and "Friends" - TheTealMango - February 23rd, 2022
- Watch: An array of voices united in anti-Zionism ('A Land With A People' featured on Al Jazeera and Mondoweiss) - Monthly Review - February 23rd, 2022
- Claudio Lomnitz and the Lost History of Latin American Jewry - The Nation - February 23rd, 2022
- 'You'll be left on your own': The unmasking of Netanyahu's politics - Haaretz - February 23rd, 2022
- Beyond the hamantash: Traditional Purim dishes tell the story of Diaspora life - Cleveland Jewish News - February 23rd, 2022
- West Side Rag It's Shabbat and the Challahs Are Baking - westsiderag.com - February 11th, 2022
- Crohn's Disease and Colorectal Cancer Risk: What to Know - Healthline - February 11th, 2022
- Who Is Cindy Landon? And What Is Her Net Worth? - Vizaca.com - February 11th, 2022
- Middle East Expert to The Media Line: Expect Iron Dome to UAE - The Media Line - January 30th, 2022
- Goga Ashkenazi - Wikipedia - January 28th, 2022
- The Flying Camel: The Mizrahi feminist who stopped ... - January 28th, 2022
- I don't have a 'Jewish' name, and people won't leave me alone about it J. - The Jewish News of Northern California - January 28th, 2022
- The all-consuming drive to oust Netanyahu has strangled us - Haaretz - January 28th, 2022
- A substantial prehistoric European ancestry amongst ... - January 7th, 2022
- Yiddishists Search for Community to Preserve Revered Language - Jewish Exponent - January 7th, 2022
- 'Licorice Pizza' Captures the Moment When Pop Culture Finally Started to See Jewish Women as Beautiful - Jewish Exponent - January 7th, 2022
- A new museum tells the story of Singapores Jews, starting with their Baghdad roots - JTA News - Jewish Telegraphic Agency - January 7th, 2022
- When It Comes to Soup, Looks Aren't Everything - Tablet Magazine - January 7th, 2022
- The Dairy Industry Is Determined to Pour Itself Down Our Throats - NewsClick - January 7th, 2022
- The dairy industry is determined to pour itself down our throats - NationofChange - January 4th, 2022
- The New York Jew Is Dead. Long Live the New York Jew - Jewish Week - January 4th, 2022
- 7 of the Best Cybersecurity Stocks for 2022 to Buy Now - InvestorPlace - January 4th, 2022
- Licorice Pizza captures the moment when pop culture finally started to see Jewish women as beautiful - JTA News - Jewish Telegraphic Agency - January 1st, 2022
- Around The World In 11 Fabulous Dumplings - LAist - January 1st, 2022
- My wife gave me a DNA test kit for Hanukkah. The family secrets it revealed changed my life - Forward - January 1st, 2022
- Liberals With Tin Ears - The American Prospect - December 18th, 2021
- Lyric Fest Presents 'Yiddishe Nightingale,' a Short History of the American Yiddish Theater - OperaWire - December 18th, 2021
- My father, the white supremacist - Vox.com - December 18th, 2021
- ArtsWatch Weekly: Tiny Tims and klezmer clarinets - Oregon ArtsWatch - December 18th, 2021
- The Weekly Covet: The Best Things We Bought This Year - TownandCountrymag.com - December 18th, 2021
- In 'Nature': The need to update neutrino models - William & Mary News - December 13th, 2021
- Tel Aviv: poverty and eviction in the worlds most expensive city - The Guardian - December 13th, 2021
- A Jewish culinary renaissance is expanding the definition of kosher food KION546 - KION - December 13th, 2021
- Feyenoord 2-1 Mac. Haifa: results, summary and goals - AS English - December 13th, 2021
- Why do Jews have such a love affair with the IDF? - St. Louis Jewish Light - December 13th, 2021
- Being The Ricardos: I Love Lucy But Not This Film - Solzy at the Movies - December 13th, 2021
- 'TARO::TORA' artist Ava Sakaya Rosen's Torah-inspired tarot deck J. - The Jewish News of Northern California - December 4th, 2021
Comments